- Home
- MRK vs NVVEW Comparison
MRK vs NVVEW Comparison
Compare MRK & NVVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | NVVEW |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | China |
| Employees | N/A | 12 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | N/A |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MRK | NVVEW |
|---|---|---|
| Price | $99.75 | $0.01 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $110.33 | N/A |
| AVG Volume (30 Days) | ★ 15.9M | N/A |
| Earning Date | 10-30-2025 | N/A |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $64,235,000,000.00 | N/A |
| Revenue This Year | $1.97 | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | $13.10 | ★ N/A |
| Revenue Growth | ★ 1.68 | N/A |
| 52 Week Low | $73.31 | N/A |
| 52 Week High | $105.84 | N/A |
Technical Indicators
Market Signals| Indicator | MRK | NVVEW |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 37.62 |
| Support Level | $96.06 | $0.01 |
| Resistance Level | $99.85 | $0.02 |
| Average True Range (ATR) | 2.46 | 0.00 |
| MACD | -0.74 | -0.00 |
| Stochastic Oscillator | 37.10 | 11.01 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.